NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Journal Article (Journal Article)
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E-mutated anaplastic thyroid carcinoma.
Full Text
Duke Authors
Cited Authors
- Haddad, RI; Nasr, C; Bischoff, L; Busaidy, NL; Byrd, D; Callender, G; Dickson, P; Duh, Q-Y; Ehya, H; Goldner, W; Haymart, M; Hoh, C; Hunt, JP; Iagaru, A; Kandeel, F; Kopp, P; Lamonica, DM; McIver, B; Raeburn, CD; Ridge, JA; Ringel, MD; Scheri, RP; Shah, JP; Sippel, R; Smallridge, RC; Sturgeon, C; Wang, TN; Wirth, LJ; Wong, RJ; Johnson-Chilla, A; Hoffmann, KG; Gurski, LA
Published Date
- December 2018
Published In
Volume / Issue
- 16 / 12
Start / End Page
- 1429 - 1440
PubMed ID
- 30545990
Electronic International Standard Serial Number (EISSN)
- 1540-1413
Digital Object Identifier (DOI)
- 10.6004/jnccn.2018.0089
Language
- eng
Conference Location
- United States